Trinity Financial Advisors
PFE icon

Trinity Financial Advisors’s Pfizer PFE Stock Holding History

Trinity Financial Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$268K Sell
9,380
-879
-9% -$23.4K 0.07% 84
2026
Q2 		$247K Buy
10,259
+14
+0.1% +$366 0.06% 85
2026
Q1 		$288K Buy
10,245
+14
+0.1% +$373 0.08% 76
2025
Q4 		$255K Buy
10,231
+14
+0.1% +$353 0.07% 83
2025
Q3 		$260K Buy
10,217
+14
+0.1% +$346 0.08% 87
2025
Q2 		$247K Buy
10,203
+15
+0.1% +$350 0.08% 81
2025
Q1 		$247K Buy
10,188
+12
+0.1% +$314 0.09% 76
2024
Q4 		$271K Buy
10,176
+3
+0% +$81 0.1% 66
2024
Q3 		$282K Sell
10,173
-110
-1% -$3.21K 0.13% 63
2024
Q2 		$288K Buy
10,283
+12
+0.1% +$330 0.13% 62
2024
Q1 		$285K Buy
10,271
+143
+1% +$3.97K 0.13% 58
2023
Q4 		$292K Sell
10,128
-337
-3% -$10.2K 0.14% 58
2023
Q3 		$347K Buy
10,465
+9
+0.1% +$318 0.18% 48
2023
Q2 		$384K Buy
10,456
+7
+0.1% +$272 0.21% 51
2023
Q1 		$426K Buy
10,449
+8
+0.1% +$346 0.26% 42
2022
Q4 		$535K Buy
10,441
+5
+0% +$240 0.35% 29
2022
Q3 		$457K Sell
10,436
-8,391
-45% -$408K 0.33% 37
2022
Q2 		$987K Buy
18,827
+8,253
+78% +$421K 0.73% 19
2022
Q1 		$547K Sell
10,574
-274
-3% -$14.2K 0.34% 28
2021
Q4 		$641K Buy
10,848
+5
+0% +$248 0.38% 21
2021
Q3 		$466K Buy
10,843
+6
+0.1% +$266 0.31% 22
2021
Q2 		$424K Sell
10,837
-86
-0.8% -$3.34K 0.3% 29
2021
Q1 		$396K Sell
10,923
-41
-0.4% -$1.46K 0.31% 26
2020
Q4 		$404K Buy
+10,964
New +$402K 0.37% 33

Other funds holding PFE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Trinity Financial Advisors's PFE Position: Q3 2026 in Review

Trinity Financial Advisors reduced its Pfizer (PFE) stake by 8.6% in Q3 2026, selling an estimated $23.4K and leaving 9,380 shares worth $268K. The position accounts for 0.07% of the portfolio, ranked #84.

Trinity Financial Advisors first reported a position in PFE in Q4 2020 and has held it in 24 quarters since. The position peaked at $987K in Q2 2022. 1,743 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Trinity Financial Advisors held 9,380 shares of Pfizer worth $268K as of Q3 2026.
  • Trinity Financial Advisors sold 879 Pfizer shares in Q3 2026, an estimated $23.4K.
  • Pfizer made up 0.07% of Trinity Financial Advisors's portfolio in Q3 2026, its #84 holding.
  • Trinity Financial Advisors first reported a position in Pfizer in Q4 2020 and has held it in 24 quarters since.
  • Trinity Financial Advisors's Pfizer position peaked at $987K in Q2 2022.
  • 1,743 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Trinity Financial Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.